UroGen Pharma
URGN
URGN
84 hedge funds and large institutions have $527M invested in UroGen Pharma in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+10
Holders Change %
+13.51%
% of All Funds
1.83%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
25
Increased
27
Reduced
19
Closed
14
Calls
$1.44M
Puts
$553K
Net Calls
+$888K
Net Calls Change
-$47K
Top Buyers
| 1 |
BlackRock
New York
|
+$32.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.4M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$3.7M |
| 4 |
DG
Delek Group
Herzliya,
Israel
|
+$3.34M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.18M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$11.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.41M |
| 3 |
Man Group
London,
United Kingdom
|
-$5.84M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.44M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.26M |
